Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 12, 2007 - Issue 2
Submit an article Journal homepage
324
Views
24
CrossRef citations to date
0
Altmetric
Perspective

A novel perspective on natural therapeutic approaches in glaucoma therapy

Maneli Mozaffarieh MD University Eye Clinic Basel, Mittlere Strasse 91, PO Box, CH-4031 Basel, Switzerland +41 61 2658633; +41 612658652; [email protected]
&
Josef Flammer MD University Eye Clinic Basel, Mittlere Strasse 91, PO Box, CH-4031 Basel, Switzerland +41 61 2658633; +41 612658652; [email protected]
Pages 195-198 | Published online: 29 Jun 2007

Bibliography

  • FLAMMER J: Glaucoma. A Guide for Patients. An Introduction for Care Providers. A Quick Reference (3rd, completely revised edition). Hogrefe and Huber, Bern, Switzerland (2006).
  • FLAMMER J, DRANCE SM: Correlation between color vision scores and quantitative perimetry in suspected glaucoma. Arch. Ophthalmol. (1984) 102:38-39.
  • FLAMMER J, DRANCE SM, AUGUSTINY L et al.: Quantification of glaucomatous visual field defects with automated perimetry. Invest Ophthalmol. Vis. Sci. (1985) 26:176-181.
  • ASRANI S, ZEIMER R, WILENSKY J et al.: Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J. Glaucoma. (2000) 9:134-142.
  • GIUFFRE I, TAVERNITI L, DI SS: The effects of 2% ibopamine eye drops on the intraocular pressure and pupil motility of patients with open-angle glaucoma.Eur. J. Ophthalmol. (2004) 14:508-513.
  • GUGLETA K, ORGUL S, FLAMMER J: Asymmetry in intraocular pressure and retinal nerve fiber layer thickness in normal-tension glaucoma. Ophthalmologica (1999) 213:219-223.
  • KOCAK I, ORGUL S, SARUHAN A et al.: Measurement of intraocular pressure with a modern noncontact tonometer. Ophthalmologica (1998) 212:81-87.
  • MORRISON JC: Elevated intraocular pressure and optic nerve injury models in the rat. J. Glaucoma. (2005) 14:315-317.
  • NIESEL P, FLAMMER J: Correlations between intraocular pressure, visual field and visual acuity, based on 11 years of observations of treated chronic glaucomas. Int. Ophthalmol. (1980) 3:31-35.
  • FLAMMER J: [Normal-pressure glaucoma]. Fortschr. Ophthalmol. (1990) 87(Suppl.):S187-S189.
  • PACHE M, FLAMMER J: A sick eye in a sick body? Systemic findings in patients with primary open-angle glaucoma. Surv. Ophthalmol. (2006) 51:179-212.
  • FLAMMER J: The vascular concept of glaucoma. Surv. Ophthalmol. (1994) 38(Suppl.):S3-S6.
  • FLAMMER J, ORGUL S: Optic nerve blood-flow abnormalities in glaucoma. Prog. Retin. Eye Res. (1998) 17:267-289.
  • FLAMMER J, HAEFLIGER IO, ORGUL S et al.: Vascular dysregulation: a principal risk factor for glaucomatous damage? J. Glaucoma. (1999) 8:212-219.
  • FLAMMER J: [Glaucomatous optic neuropathy: a reperfusion injury] Klin. Monatsbl. Augenheilkd. (2001) 218:290-291.
  • FLAMMER J, ORGUL S, COSTA VP et al.: The impact of ocular blood flow in glaucoma. Prog. Retin. Eye Res. (2002) 21:359-393.
  • GRIESHABER MC, FLAMMER J: Blood flow in glaucoma. Curr. Opin. Ophthalmol. (2005) 16:79-83.
  • GUGLETA K, ORGUL S, FLAMMER I: Reliability of confocal choroidal laser Doppler flowmetry. Invest. Ophthalmol. Vis. Sci. (2002) 43:723-728.
  • GUGLETA K, ORGUL S, HASLER PW et al.: Choroidal vascular reaction to hand-grip stress in subjects with vasospasm and its relevance in glaucoma. Invest. Ophthalmol. Vis. Sci. (2003) 44:1573-1580.
  • IZZOTTI A, SACCA SC, CARTIGLIA C et al.: Oxidative deoxyribonucleic acid damage in the eyes of glaucoma patients. Am. J. Med. (2003) 114:638-646.
  • IZZOTTI A, BAGNIS A, SACCA SC: The role of oxidative stress in glaucoma. Mutat. Res. (2006) 612:105-114.
  • LUTHRA A, GUPTA N, KAUFMAN PL et al.: Oxidative injury by peroxynitrite in neural and vascular tissue of the lateral geniculate nucleus in experimental glaucoma. Exp. Eye Res. (2005) 80:43-49.
  • TAMM ER, RUSSELL P, JOHNSON DH et al.: Human and monkey trabecular meshwork accumulate alpha B-crystallin in response to heat shock and oxidative stress. Invest. Ophthalmol. Vis. Sci. (1996) 37:2402-2413.
  • TEZEL G: Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog. Retin. Eye Res. (2006) 25:490-513.
  • ZHOU L, LI Y, YUE BY: Oxidative stress affects cytoskeletal structure and cell-matrix interactions in cells from an ocular tissue: the trabecular meshwork. J. Cell Physiol. (1999) 180:182-189.
  • FLAMMER J, PACHE M, RESINK T: Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog. Retin. Eye Res. (2001) 20:319-349.
  • TURRENS JF: Mitochondrial formation of reactive oxygen species. J. Physiol. (2003) 552:335-344.
  • NEUFELD AH, LIU B: Glaucomatous optic neuropathy: when glia misbehave. Neuroscientist. (2003) 9:485-495.
  • HAEFLIGER IO, DETTMANN E, LIU R et al.: Potential role of nitric oxide and endothelin in the pathogenesis of glaucoma. Surv. Ophthalmol. (1999) 43(Suppl. 1):S51-S58.
  • NEUFELD AH, HERNANDEZ MR, GONZALEZ M: Nitric oxide synthase in the human glaucomatous optic nerve head. Arch. Ophthalmol. (1997) 115:497-503.
  • FLAMMER J, HENDRICKSON P, LIETZ A et al.: Swivel arm perimeter for visual field testing in different body positions. Ophthalmologica (1993) 206:15-17.
  • GUGLETA K, ORGUL S, STUMPFIG D et al.: Fludrocortisone in the treatment of systemic hypotension in primary open-angle glaucoma patients. Int. Ophthalmol. (1999) 23:25-30.
  • GASPAR AZ, GASSER P, FLAMMER J: The influence of magnesium on visual field and peripheral vasospasm in glaucoma. Ophthalmologica (1995) 209:11-13.
  • CELLINI M, CARAMAZZA N, MANGIAFICO P et al.: Fatty acid use in glaucomatous optic neuropathy treatment. Acta Ophthalmol. Scand. Suppl. (1998) 41-42.
  • ENGLER MB: Effects of omega-3, omega-6 and omega-9 fatty acids on vascular smooth muscle tone. Eur. J. Pharmacol. (1992) 215:325-328.
  • ENGLER MB, ENGLER MM: The emerging role of flavonoid-rich cocoa and chocolate in cardiovascular health and disease. Nutr. Rev. (2006) 64:109-118.
  • HEISS C, DEJAM A, KLEINBONGARD P et al.: Vascular effects of cocoa rich in flavan-3-ols. JAMA (2003) 290:1030-1031.
  • VINSON JA, PROCH J, ZUBIK L: Phenol antioxidant quantity and quality in foods: cocoa, dark chocolate, and milk chocolate. J. Agric. Food Chem. (1999) 47:4821-4824.
  • GRASSI D, NECOZIONE S, LIPPI C et al.: Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension (2005) 46:398-405.
  • ECKERT A, KEIL U, KRESSMANN S et al.: Effects of EGb 761 Ginkgo biloba extract on mitochondrial function and oxidative stress. Pharmacopsychiatry (2003) 36(Suppl. 1):S15-S23.
  • ECKERT A, KEIL U, SCHERPING I et al.: Stabilization of mitochondrial membrane potential and improvement of neuronal energy metabolism by Ginkgo biloba extract EGb 761. Ann. N YAcad. Sci. (2005) 1056:474-485.
  • RITCH R: Potential role for Ginkgo biloba extract in the treatment of glaucoma. Med. Hypotheses (2000) 54:221-235.
  • RITCH R: Neuroprotection: is it already applicable to glaucoma therapy? Curr. Opin. Ophthalmol. (2000) 11:78-84.
  • HIROOKA K, TOKUDA M, MIYAMOTO O et al.: The Ginkgo biloba extract (EGb 761) provides a neuroprotective effect on retinal ganglion cells in a rat model of chronic glaucoma. Curr. Eye Res. (2004) 28:153-157.
  • QUARANTA L, BETTELLI S, UVA MG et al.: Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology (2003) 110:359-362.
  • MANDEL S, AMIT T, REZNICHENKO L et al.: Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disorders. Mol. Nutr. Food Res. (2006) 50:229-234.
  • SUTHERLAND BA, RAHMAN RM, APPLETON I: Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration. J. Nutr. Biochem. (2006) 17:291-306.
  • ZHAO B: Natural antioxidants for neurodegenerative diseases. Mol. Neurobiol. (2005) 31:283-293.
  • HUANG J, DE PT, MAY JM: Antioxidant effects of dihydrocaffeic acid in human EA. hy926 endothelial cells. J. Nutr. Biochem. (2004) 15:722-729.
  • YEN WJ, WANG BS, CHANG LW et al.: Antioxidant properties of roasted coffee residues. J. Agric. Food Chem. (2005) 53:2658-2663.
  • MILLER KB, STUART DA, SMITH NL et al.: Antioxidant activity and polyphenol and procyanidin contents of selected commercially available cocoa-containing and chocolate products in the United States. J. Agric. Food Chem. (2006) 54:4062-4068.
  • HAUFSCHILD T, KAISER HJ, PREISIG T et al.: Influence of red wine on visual function and endothelin-1 plasma level in a patient with optic neuritis. Ann. Neurol. (2003) 53:825-826.
  • SINGLETON VL, ESAU P: Phenolic substances in grapes and wine, and their significance. Adv. Food Res. Suppl. (1969) 1:1-261.
  • KIM AR, ZOU Y, KIM HS et al.: Selective peroxynitrite scavenging activity of 3-methyl-1,2-cyclopentanedione from coffee extract. J. Pharm. Pharmacol. (2002) 54:1385-1392.
  • KATSUBE N, IWASHITA K, TSUSHIDA T et al.: Induction of apoptosis in cancer cells by Bilberry (Vaccinium myrtillus) and the anthocyanins. J. Agric. Food Chem. (2003) 51:68-75.
  • MAATTA-RIIHINEN KR, KAHKONEN MP, TORRONEN AR et al.: Catechins and procyanidins in berries of vaccinium species and their antioxidant activity. J. Agric. Food Chem. (2005) 53:8485-8491.
  • FUJISAWA S, KADOMA Y: Kinetic study of the radical-scavenging activity of vitamin E and ubiquinone. In Vivo (2005) 19:1005-1011.
  • KAGAN V, SERBINOVA E, PACKER L: Antioxidant effects of ubiquinones in microsomes and mitochondria are mediated by tocopherol recycling. Biochem. Biophys. Res. Commun. (1990) 169:851-857.
  • CHETSAWANG B, PUTTHAPRASART C, PHANSUWAN-PUJITO P et al.: Melatonin protects against hydrogen peroxide-induced cell death signaling in SH-SY5Y cultured cells: involvement of nuclear factor kappa B Bax and Bcl-2. J. Pineal Res. (2006) 41:116-123.
  • ARDELAND R: Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine. (2005) 27:119-130.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.